In this context, a study of Nie et al. [2] explored the role of the lncRNA antisense noncoding RNA gene at the INK4 locus (hereafter referred to as ANRIL) in NSCLC progression. This evidence concerns the gene CDKN2B-AS1 and non-small cell lung carcinoma.